183 related articles for article (PubMed ID: 15952173)
1. Decreased FOXP3 levels in multiple sclerosis patients.
Huan J; Culbertson N; Spencer L; Bartholomew R; Burrows GG; Chou YK; Bourdette D; Ziegler SF; Offner H; Vandenbark AA
J Neurosci Res; 2005 Jul; 81(1):45-52. PubMed ID: 15952173
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis.
Compston A; Coles A
Lancet; 2008 Oct; 372(9648):1502-17. PubMed ID: 18970977
[TBL] [Abstract][Full Text] [Related]
3. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
4. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis and regulatory T cells.
Costantino CM; Baecher-Allan C; Hafler DA
J Clin Immunol; 2008 Nov; 28(6):697-706. PubMed ID: 18763026
[TBL] [Abstract][Full Text] [Related]
6. Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression.
Venken K; Hellings N; Broekmans T; Hensen K; Rummens JL; Stinissen P
J Immunol; 2008 May; 180(9):6411-20. PubMed ID: 18424765
[TBL] [Abstract][Full Text] [Related]
7. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
Haas J; Hug A; Viehöver A; Fritzsching B; Falk CS; Filser A; Vetter T; Milkova L; Korporal M; Fritz B; Storch-Hagenlocher B; Krammer PH; Suri-Payer E; Wildemann B
Eur J Immunol; 2005 Nov; 35(11):3343-52. PubMed ID: 16206232
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells in autoimmune neuroinflammation.
Kleinewietfeld M; Hafler DA
Immunol Rev; 2014 May; 259(1):231-44. PubMed ID: 24712469
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells.
Morikawa H; Sakaguchi S
Immunol Rev; 2014 May; 259(1):192-205. PubMed ID: 24712467
[TBL] [Abstract][Full Text] [Related]
10. Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells.
Hori S
Immunol Rev; 2014 May; 259(1):159-72. PubMed ID: 24712465
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory cytokine IL-35 contributes to regulatory T-cell function.
Collison LW; Workman CJ; Kuo TT; Boyd K; Wang Y; Vignali KM; Cross R; Sehy D; Blumberg RS; Vignali DA
Nature; 2007 Nov; 450(7169):566-9. PubMed ID: 18033300
[TBL] [Abstract][Full Text] [Related]
12. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b
Arellano G; Acuña E; Loda E; Moore L; Tichauer JE; Castillo C; Vergara F; Burgos PI; Penaloza-MacMaster P; Miller SD; Naves R
J Neuroinflammation; 2024 May; 21(1):144. PubMed ID: 38822334
[TBL] [Abstract][Full Text] [Related]
14. Causal association between the peripheral immunity and the risk and disease severity of multiple sclerosis.
Chen L; Zhu LF; Zhang LY; Chu YH; Dong MH; Pang XW; Yang S; Zhou LQ; Shang K; Xiao J; Wang W; Qin C; Tian DS
Front Immunol; 2024; 15():1325938. PubMed ID: 38390334
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Suppressive Activity and Proliferation of Human Regulatory T Cells by Splice-Switching Oligonucleotides Targeting FoxP3 Pre-mRNA.
Blinova VG; Gladilina YA; Abramova AA; Eliseeva DD; Vtorushina VV; Shishparenok AN; Zhdanov DD
Cells; 2023 Dec; 13(1):. PubMed ID: 38201281
[TBL] [Abstract][Full Text] [Related]
16. Inflammation as common link to progressive neurological diseases.
Dias-Carvalho A; Sá SI; Carvalho F; Fernandes E; Costa VM
Arch Toxicol; 2024 Jan; 98(1):95-119. PubMed ID: 37964100
[TBL] [Abstract][Full Text] [Related]
17. Lrig1-expression confers suppressive function to CD4
Moon JS; Ho CC; Park JH; Park K; Shin BY; Lee SH; Sequeira I; Mun CH; Shin JS; Kim JH; Kim BS; Noh JW; Lee ES; Son JY; Kim Y; Lee Y; Cho H; So S; Park J; Choi E; Oh JW; Lee SW; Morio T; Watt FM; Seong RH; Lee SK
Nat Commun; 2023 Sep; 14(1):5382. PubMed ID: 37666819
[TBL] [Abstract][Full Text] [Related]
18. Tehranolid and Artemisinin Effects on Ameliorating Experimental Autoimmune Encephalomyelitis by Modulating Inflammation and Remyelination.
Salehi N; Nourbakhsh M; Noori S; Rezaeizadeh H; Zarghi A
Mol Neurobiol; 2023 Oct; 60(10):5975-5986. PubMed ID: 37391648
[TBL] [Abstract][Full Text] [Related]
19. T cells in health and disease.
Sun L; Su Y; Jiao A; Wang X; Zhang B
Signal Transduct Target Ther; 2023 Jun; 8(1):235. PubMed ID: 37332039
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Experimental Autoimmune Encephalomyelitis in Mice by β-Hydroxy β-Methylbutyrate, a Body-Building Supplement in Humans.
Sheinin M; Mondal S; Roy A; Gorai S; Rangasamy SB; Poddar J; Pahan K
J Immunol; 2023 Jul; 211(2):187-198. PubMed ID: 37314416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
